Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Novartis receives approvable letter for Diovan as treatment for heart failure

Oct. 26, 2001

European Generx trial approved and set to commence

Oct. 26, 2001

ALT-711 enters a second systolic hypertension trial

Oct. 25, 2001

Induction of therapeutic angiogenesis by molgramostim in patients with CAD

Oct. 25, 2001

Vasopeptidase inhibitors from Bioprojet to be developed, marketed by Lilly

Oct. 25, 2001

Clinical trials of Remicade for congestive heart failure put on hold

Oct. 24, 2001

Use of SSRIs may reduce risk of myocardial infarction in smokers

Oct. 24, 2001

First patients enrolled in paclitaxel-eluting coronary stent trial

Oct. 24, 2001

Phase II trials of new treatment for atrial fibrillation set to begin

Oct. 23, 2001

Sangamo achieves first milestone in ZFP therapeutics program

Oct. 23, 2001

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...